BACKGROUND: Vitamin D deficiency in noncancer patients is associated with symptoms of fatigue, muscle weakness, and depression. These symptoms are common among advanced cancer patients. We investigated the prevalence of low serum vitamin D levels in cancer patients with fatigue or poor appetite and their association with symptom burden and other correctable endocrine abnormalities. METHODS: This was a retrospective review of 100 consecutive cancer patients with appetite or fatigue scores of ≥4 of 10 referred to a supportive care clinic. We investigated serum levels of 25(OH) vitamin D, cortisol, thyroid-stimulating hormone, and bioavailable testosterone. Symptoms were measured by the Edmonton Symptom Assessment Scale. Serum 25(OH) vitamin D <20 ng/mL was considered deficient; ≥20 ng/mL and <30 ng/mL were considered insufficient. RESULTS: Patients were predominantly male (68%) and white (66%), with a median age of 60 years (range, 27-91 years). Gastrointestinal (30%) and lung (22%) cancers were predominant. Forty-seven patients (47%) were vitamin D deficient and 70 (70%) were insufficient. Thirteen of 70 patients (19%) with vitamin D insufficiency were on supplementation. Vitamin D deficiency was more common among nonwhites (82% versus 36%) and females. No significant association was found between vitamin D and symptoms. Hypogonadic males had a significantly lower mean 25(OH) vitamin D level than eugonadic males. CONCLUSIONS: Low vitamin D levels were highly prevalent among advanced cancer patients with cachexia or fatigue. Vitamin D deficiency was more frequent among nonwhite and female patients. Vitamin D levels were also significantly lower in male patients with hypogonadism.
BACKGROUND:Vitamin D deficiency in noncancer patients is associated with symptoms of fatigue, muscle weakness, and depression. These symptoms are common among advanced cancerpatients. We investigated the prevalence of low serum vitamin D levels in cancerpatients with fatigue or poor appetite and their association with symptom burden and other correctable endocrine abnormalities. METHODS: This was a retrospective review of 100 consecutive cancerpatients with appetite or fatigue scores of ≥4 of 10 referred to a supportive care clinic. We investigated serum levels of 25(OH) vitamin D, cortisol, thyroid-stimulating hormone, and bioavailable testosterone. Symptoms were measured by the Edmonton Symptom Assessment Scale. Serum 25(OH) vitamin D <20 ng/mL was considered deficient; ≥20 ng/mL and <30 ng/mL were considered insufficient. RESULTS:Patients were predominantly male (68%) and white (66%), with a median age of 60 years (range, 27-91 years). Gastrointestinal (30%) and lung (22%) cancers were predominant. Forty-seven patients (47%) were vitamin D deficient and 70 (70%) were insufficient. Thirteen of 70 patients (19%) with vitamin Dinsufficiency were on supplementation. Vitamin D deficiency was more common among nonwhites (82% versus 36%) and females. No significant association was found between vitamin D and symptoms. Hypogonadic males had a significantly lower mean 25(OH) vitamin D level than eugonadic males. CONCLUSIONS: Low vitamin D levels were highly prevalent among advanced cancerpatients with cachexia or fatigue. Vitamin D deficiency was more frequent among nonwhite and female patients. Vitamin D levels were also significantly lower in male patients with hypogonadism.
Authors: Leon Flicker; Robert J MacInnis; Mark S Stein; Sam C Scherer; Kate E Mead; Caryl A Nowson; Jenny Thomas; Chris Lowndes; John L Hopper; John D Wark Journal: J Am Geriatr Soc Date: 2005-11 Impact factor: 5.562
Authors: P N Sambrook; I D Cameron; J S Chen; R G Cumming; S Durvasula; M Herrmann; C Kok; S R Lord; M Macara; L M March; R S Mason; M J Seibel; N Wilson; J M Simpson Journal: Osteoporos Int Date: 2011-03-03 Impact factor: 4.507
Authors: V G Chel; M E Ooms; C Popp-Snijders; S Pavel; A A Schothorst; C C Meulemans; P Lips Journal: J Bone Miner Res Date: 1998-08 Impact factor: 6.741
Authors: Adam Morton; Janet Hardy; Anthony Morton; Angela Tapuni; Helen Anderson; Ngaire Kingi; Catherine Shannon Journal: Support Care Cancer Date: 2014-03-25 Impact factor: 3.603
Authors: Peter Bergman; Susanne Sperneder; Jonas Höijer; Jenny Bergqvist; Linda Björkhem-Bergman Journal: PLoS One Date: 2015-05-27 Impact factor: 3.240
Authors: Grégoire B Morand; Sabrina Daniela da Silva; Michael P Hier; Moulay A Alaoui-Jamali Journal: Front Oncol Date: 2014-11-04 Impact factor: 6.244
Authors: Daniel C McFarland; Madalyn Fernbach; William S Breitbart; Christian Nelson Journal: BMJ Support Palliat Care Date: 2020-08-27 Impact factor: 4.633